Status:
NOT_YET_RECRUITING
Correlation Study Between the Classification of Arthrogenic Motor Inhibition (AMI) and Clinical Assessment After ACL Rupture
Lead Sponsor:
GCS Ramsay Santé pour l'Enseignement et la Recherche
Conditions:
ACL - Anterior Cruciate Ligament Rupture
Eligibility:
All Genders
18-44 years
Phase:
NA
Brief Summary
The goal of this interventional study is to measure medial vastus inhibition and associate it with AMI classification in patients with ACL rupture. The main question it aims to answer is: Is there a ...
Eligibility Criteria
Inclusion
- Patient, male or female, aged ≥ 18 years and \< 45 years
- Patient with an ACL rupture confirmed by MRI
- Patient with an ACL rupture ≤ 30 days old
- French speaking patient who does not object to the use of his/her data
Exclusion
- Patient with previous ipsi or contralateral knee injury/surgery
- Patient with multi-ligament injury
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06945133
Start Date
December 1 2025
End Date
December 31 2026
Last Update
November 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé Jean Mermoz
Lyon, France, 69008